STOCK TITAN

[8-K] Ally Financial Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

AMERISAFE, Inc. (AMSF) filed an 8-K on 24-Jul-2025 to disclose that its Board has reauthorized a share-repurchase program of up to $25.0 million. The new authorization replaces the prior program and carries no expiration date. Repurchases may be executed in the open market or through Rule 10b5-1 trading plans and will be funded with available capital. The Board retains full discretion to modify, suspend, increase or terminate the program at any time, based on market conditions and regulatory factors. The filing contains no earnings data and does not obligate the company to repurchase any specific amount of shares.

AMERISAFE, Inc. (AMSF) ha presentato un modulo 8-K il 24 luglio 2025 per comunicare che il suo Consiglio di Amministrazione ha riautorizzato un programma di riacquisto di azioni fino a 25,0 milioni di dollari. La nuova autorizzazione sostituisce il programma precedente e non ha una data di scadenza. I riacquisti possono essere effettuati sul mercato aperto o tramite piani di negoziazione secondo la Regola 10b5-1 e saranno finanziati con capitale disponibile. Il Consiglio mantiene la piena discrezione di modificare, sospendere, aumentare o terminare il programma in qualsiasi momento, in base alle condizioni di mercato e ai fattori normativi. Il documento non contiene dati sugli utili e non obbliga la società a riacquistare una quantità specifica di azioni.

AMERISAFE, Inc. (AMSF) presentó un formulario 8-K el 24 de julio de 2025 para informar que su Junta Directiva ha reautorizado un programa de recompra de acciones por hasta 25,0 millones de dólares. La nueva autorización reemplaza el programa anterior y no tiene fecha de vencimiento. Las recompras pueden ejecutarse en el mercado abierto o a través de planes de negociación bajo la Regla 10b5-1 y se financiarán con capital disponible. La Junta mantiene plena discreción para modificar, suspender, aumentar o terminar el programa en cualquier momento, según las condiciones del mercado y factores regulatorios. El documento no contiene datos de ganancias y no obliga a la empresa a recomprar una cantidad específica de acciones.

AMERISAFE, Inc.(AMSF)는 2025년 7월 24일 8-K 보고서를 제출하여 이사회의 주식 재매입 프로그램을 최대 2,500만 달러까지 재승인했다고 밝혔습니다. 이번 새로운 승인으로 이전 프로그램은 대체되며 만료일이 없습니다. 재매입은 공개 시장에서 또는 Rule 10b5-1 거래 계획을 통해 실행될 수 있으며, 사용 가능한 자본으로 자금이 조달됩니다. 이사회는 시장 상황과 규제 요인을 고려하여 언제든지 프로그램을 수정, 중단, 확대 또는 종료할 수 있는 전권을 보유합니다. 제출된 보고서에는 수익 데이터가 포함되어 있지 않으며 회사가 특정 수량의 주식을 반드시 재매입해야 하는 의무는 없습니다.

AMERISAFE, Inc. (AMSF) a déposé un formulaire 8-K le 24 juillet 2025 pour annoncer que son conseil d'administration a réautorisé un programme de rachat d'actions pouvant aller jusqu'à 25,0 millions de dollars. La nouvelle autorisation remplace le programme précédent et n'a pas de date d'expiration. Les rachats peuvent être effectués sur le marché ouvert ou via des plans de négociation conformes à la règle 10b5-1 et seront financés avec des capitaux disponibles. Le conseil conserve la pleine discrétion de modifier, suspendre, augmenter ou mettre fin au programme à tout moment, en fonction des conditions du marché et des facteurs réglementaires. Le dépôt ne contient pas de données sur les bénéfices et n'oblige pas la société à racheter un nombre spécifique d'actions.

AMERISAFE, Inc. (AMSF) reichte am 24. Juli 2025 ein 8-K ein, um bekannt zu geben, dass der Vorstand ein Aktienrückkaufprogramm in Höhe von bis zu 25,0 Millionen US-Dollar erneut genehmigt hat. Die neue Genehmigung ersetzt das vorherige Programm und hat kein Ablaufdatum. Rückkäufe können am offenen Markt oder über Rule 10b5-1 Handelspläne durchgeführt werden und werden mit verfügbarem Kapital finanziert. Der Vorstand behält sich das volle Ermessen vor, das Programm jederzeit basierend auf Marktbedingungen und regulatorischen Faktoren zu ändern, auszusetzen, zu erhöhen oder zu beenden. Die Einreichung enthält keine Gewinnzahlen und verpflichtet das Unternehmen nicht zum Rückkauf einer bestimmten Anzahl von Aktien.

Positive
  • $25 million share-repurchase authorization renews and potentially expands capital-return capacity, demonstrating Board confidence and offering share-price support.
Negative
  • No commitment or timeline—the Board may alter or suspend the program at will, so actual repurchase volume and timing remain uncertain.

Insights

TL;DR: $25M buyback adds capital-return flexibility and could support EPS, but scale is modest.

The reauthorization signals management’s confidence in cash generation and seeks to offset share dilution or enhance shareholder returns. With no expiry, the Board can time purchases opportunistically, a prudent approach in insurance markets that can be volatile. That said, the filing gives no guidance on execution pace, leaving the actual impact dependent on utilization. Still, at up to $25 million, the program could retire roughly 3-4% of shares outstanding (based on a sub-$700M market cap in recent quarters), providing a mild EPS tailwind if fully deployed.

AMERISAFE, Inc. (AMSF) ha presentato un modulo 8-K il 24 luglio 2025 per comunicare che il suo Consiglio di Amministrazione ha riautorizzato un programma di riacquisto di azioni fino a 25,0 milioni di dollari. La nuova autorizzazione sostituisce il programma precedente e non ha una data di scadenza. I riacquisti possono essere effettuati sul mercato aperto o tramite piani di negoziazione secondo la Regola 10b5-1 e saranno finanziati con capitale disponibile. Il Consiglio mantiene la piena discrezione di modificare, sospendere, aumentare o terminare il programma in qualsiasi momento, in base alle condizioni di mercato e ai fattori normativi. Il documento non contiene dati sugli utili e non obbliga la società a riacquistare una quantità specifica di azioni.

AMERISAFE, Inc. (AMSF) presentó un formulario 8-K el 24 de julio de 2025 para informar que su Junta Directiva ha reautorizado un programa de recompra de acciones por hasta 25,0 millones de dólares. La nueva autorización reemplaza el programa anterior y no tiene fecha de vencimiento. Las recompras pueden ejecutarse en el mercado abierto o a través de planes de negociación bajo la Regla 10b5-1 y se financiarán con capital disponible. La Junta mantiene plena discreción para modificar, suspender, aumentar o terminar el programa en cualquier momento, según las condiciones del mercado y factores regulatorios. El documento no contiene datos de ganancias y no obliga a la empresa a recomprar una cantidad específica de acciones.

AMERISAFE, Inc.(AMSF)는 2025년 7월 24일 8-K 보고서를 제출하여 이사회의 주식 재매입 프로그램을 최대 2,500만 달러까지 재승인했다고 밝혔습니다. 이번 새로운 승인으로 이전 프로그램은 대체되며 만료일이 없습니다. 재매입은 공개 시장에서 또는 Rule 10b5-1 거래 계획을 통해 실행될 수 있으며, 사용 가능한 자본으로 자금이 조달됩니다. 이사회는 시장 상황과 규제 요인을 고려하여 언제든지 프로그램을 수정, 중단, 확대 또는 종료할 수 있는 전권을 보유합니다. 제출된 보고서에는 수익 데이터가 포함되어 있지 않으며 회사가 특정 수량의 주식을 반드시 재매입해야 하는 의무는 없습니다.

AMERISAFE, Inc. (AMSF) a déposé un formulaire 8-K le 24 juillet 2025 pour annoncer que son conseil d'administration a réautorisé un programme de rachat d'actions pouvant aller jusqu'à 25,0 millions de dollars. La nouvelle autorisation remplace le programme précédent et n'a pas de date d'expiration. Les rachats peuvent être effectués sur le marché ouvert ou via des plans de négociation conformes à la règle 10b5-1 et seront financés avec des capitaux disponibles. Le conseil conserve la pleine discrétion de modifier, suspendre, augmenter ou mettre fin au programme à tout moment, en fonction des conditions du marché et des facteurs réglementaires. Le dépôt ne contient pas de données sur les bénéfices et n'oblige pas la société à racheter un nombre spécifique d'actions.

AMERISAFE, Inc. (AMSF) reichte am 24. Juli 2025 ein 8-K ein, um bekannt zu geben, dass der Vorstand ein Aktienrückkaufprogramm in Höhe von bis zu 25,0 Millionen US-Dollar erneut genehmigt hat. Die neue Genehmigung ersetzt das vorherige Programm und hat kein Ablaufdatum. Rückkäufe können am offenen Markt oder über Rule 10b5-1 Handelspläne durchgeführt werden und werden mit verfügbarem Kapital finanziert. Der Vorstand behält sich das volle Ermessen vor, das Programm jederzeit basierend auf Marktbedingungen und regulatorischen Faktoren zu ändern, auszusetzen, zu erhöhen oder zu beenden. Die Einreichung enthält keine Gewinnzahlen und verpflichtet das Unternehmen nicht zum Rückkauf einer bestimmten Anzahl von Aktien.

false 0000040729 0000040729 2025-07-21 2025-07-21
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

July 21, 2025

(Date of report; date of

earliest event reported)

Commission file number: 1-3754

 

 

ALLY FINANCIAL INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   38-0572512

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

Ally Detroit Center

500 Woodward Ave.

Floor 10, Detroit, Michigan

48226

(Address of principal executive offices)

(Zip Code)

(866) 710-4623

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act (listed on the New York Stock Exchange):

 

Title of each class

 

Trading

symbols

Common Stock, par value $0.01 per share   ALLY

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 21, 2025, David J. DeBrunner notified Ally Financial Inc. (Ally) of his intention to retire as Ally’s Chief Accounting Officer and Controller. Mr. DeBrunner confirmed that his decision was based on his professional and personal priorities and was not due to any disagreement with Ally on any matter relating to Ally’s operations, policies, or practices.

Austin T. McGrath will assume the role of Chief Accounting Officer and Controller effective August 8, 2025. Mr. McGrath joined Ally in 2007. He was appointed executive director of Investor Relations in January 2025. Prior to that, Mr. McGrath served in a variety of accounting roles within the Corporate Controllers Group, most recently as executive director for SEC Reporting, Regulatory Reporting, and Risk Finance from June 2021 through January 2025. Mr. McGrath is a Certified Public Accountant and holds a bachelor’s degree in accounting from Lehigh University.

In connection with Mr. McGrath’s ’s appointment, he will receive an annual base salary, is eligible to receive incentive compensation in the form of cash and equity-based awards pursuant to Ally’s Incentive Compensation Plan and will receive other employee benefits consistent with those provided to other similarly situated employees. Mr. McGrath has no family relationships with any director or executive officer of Ally or Ally Bank. There are no arrangements or understandings between Mr. McGrath and any other person pursuant to which Mr. McGrath was selected as the Chief Accounting Officer and Controller, and there are no transactions involving Mr. McGrath that would be required to be reported under Item 404(a) of Regulation S-K.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      ALLY FINANCIAL INC.
      (Registrant)
Dated: July 24, 2025      

/s/ Jeffrey A. Belisle

            Jeffrey A. Belisle
            Corporate Secretary

FAQ

What did AMERISAFE (AMSF) announce on July 24, 2025?

The Board reauthorized a $25 million share-repurchase program with no expiration date.

Does the new buyback replace a prior program?

Yes. The $25 million authorization replaces the company’s previous repurchase program.

How will AMERISAFE fund the repurchases?

Future share purchases are expected to be funded from available capital.

Is AMERISAFE obligated to repurchase the full $25 million?

No. The program is discretionary; the Board may modify, suspend, or terminate it at any time.

Can AMERISAFE use Rule 10b5-1 trading plans?

Yes. Repurchases may occur under Rule 10b5-1 compliant trading plans.
Ally Finl Inc

NYSE:ALLY

ALLY Rankings

ALLY Latest News

ALLY Latest SEC Filings

ALLY Stock Data

12.14B
275.88M
10.54%
81.82%
2.67%
Credit Services
State Commercial Banks
Link
United States
DETROIT